Answers are grounded in this paper and cite their sources.
We provide a brief overview of clinical trial results of Janus kinase (JAK) inhibitors for treating vitiligo and discuss the trial cohorts, with an emphasis on the impact of cohort demographic composition for individuals with skin of color.
No takes yet. Share an insight, caveat, or question.
Camile Delva (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: